Perioperative levosimendan in cardiac surgery: Positive, neutral, or detrimental effects?

Int J Cardiol. 2018 Jun 1:260:53. doi: 10.1016/j.ijcard.2018.03.006.

Authors

Alessandro Putzu¹, Sara Clivio¹, Alessandro Belletti², Tiziano Cassina³

Affiliations

¹ Department of Cardiovascular Anesthesia and Intensive Care, Cardiocentro Ticino, Lugano, Switzerland.
² Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.
³ Department of Cardiovascular Anesthesia and Intensive Care, Cardiocentro Ticino, Lugano, Switzerland. Electronic address: tiziano.cassina@cardiocentro.org.

PMID: 29622454
DOI: 10.1016/j.ijcard.2018.03.006

No abstract available

Publication types

Letter
Comment

MeSH terms

Cardiac Surgical Procedures
Cardiotonic Agents
Hydrazones*
Pyridazines*
Simendan

Substances

Cardiotonic Agents
Hydrazones
Pyridazines
Simendan